P-glycoprotein and chronic rhinosinusitis
Chronic rhinosinusitis (CRS) is a heterogeneous definition that includes different disease states that usually are associated with abnormal inflammatory responses. Besides being prevalent, the mechanisms involved in its pathogenesis are not clear and there are few therapeutic options with tolerable...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cd178f20e87f485f8b7af4520b10fc8a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:cd178f20e87f485f8b7af4520b10fc8a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:cd178f20e87f485f8b7af4520b10fc8a2021-12-02T11:52:14ZP-glycoprotein and chronic rhinosinusitis2095-881110.1016/j.wjorl.2018.07.002https://doaj.org/article/cd178f20e87f485f8b7af4520b10fc8a2018-09-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2095881118300908https://doaj.org/toc/2095-8811Chronic rhinosinusitis (CRS) is a heterogeneous definition that includes different disease states that usually are associated with abnormal inflammatory responses. Besides being prevalent, the mechanisms involved in its pathogenesis are not clear and there are few therapeutic options with tolerable side effects. P-glycoprotein (P-gp) is an efflux pump responsible of extruding xenobiotics and cellular metabolites from multiple cell types. It has been widely studied in the cancer field, due to its ability to confer resistance to chemotherapy. It also promotes Type 2 helper T-cell polarizing cytokine secretion in CRS and may represent a potential target to differentiate subtypes of CRS and personalize treatment. This state-of-the-art review explores current knowledge on the participation of P-gp in the pathogenesis of CRS, the P-gp inhibition as a novel targeted therapeutic strategy and the exosomal P-gp test, a non-invasive biomarker that can represent an important advance in the field of rhinology. Keywords: Sinusitis, ATP binding cassette transporter, sub-family B, Verapamil, Exosomes, Nasal polyps, Nasal mucosaMarcel M. MiyakeAngela NoceraMichelle M. MiyakeKeAi Communications Co., Ltd.articleOtorhinolaryngologyRF1-547SurgeryRD1-811ENWorld Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 4, Iss 3, Pp 169-174 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Otorhinolaryngology RF1-547 Surgery RD1-811 |
spellingShingle |
Otorhinolaryngology RF1-547 Surgery RD1-811 Marcel M. Miyake Angela Nocera Michelle M. Miyake P-glycoprotein and chronic rhinosinusitis |
description |
Chronic rhinosinusitis (CRS) is a heterogeneous definition that includes different disease states that usually are associated with abnormal inflammatory responses. Besides being prevalent, the mechanisms involved in its pathogenesis are not clear and there are few therapeutic options with tolerable side effects. P-glycoprotein (P-gp) is an efflux pump responsible of extruding xenobiotics and cellular metabolites from multiple cell types. It has been widely studied in the cancer field, due to its ability to confer resistance to chemotherapy. It also promotes Type 2 helper T-cell polarizing cytokine secretion in CRS and may represent a potential target to differentiate subtypes of CRS and personalize treatment. This state-of-the-art review explores current knowledge on the participation of P-gp in the pathogenesis of CRS, the P-gp inhibition as a novel targeted therapeutic strategy and the exosomal P-gp test, a non-invasive biomarker that can represent an important advance in the field of rhinology. Keywords: Sinusitis, ATP binding cassette transporter, sub-family B, Verapamil, Exosomes, Nasal polyps, Nasal mucosa |
format |
article |
author |
Marcel M. Miyake Angela Nocera Michelle M. Miyake |
author_facet |
Marcel M. Miyake Angela Nocera Michelle M. Miyake |
author_sort |
Marcel M. Miyake |
title |
P-glycoprotein and chronic rhinosinusitis |
title_short |
P-glycoprotein and chronic rhinosinusitis |
title_full |
P-glycoprotein and chronic rhinosinusitis |
title_fullStr |
P-glycoprotein and chronic rhinosinusitis |
title_full_unstemmed |
P-glycoprotein and chronic rhinosinusitis |
title_sort |
p-glycoprotein and chronic rhinosinusitis |
publisher |
KeAi Communications Co., Ltd. |
publishDate |
2018 |
url |
https://doaj.org/article/cd178f20e87f485f8b7af4520b10fc8a |
work_keys_str_mv |
AT marcelmmiyake pglycoproteinandchronicrhinosinusitis AT angelanocera pglycoproteinandchronicrhinosinusitis AT michellemmiyake pglycoproteinandchronicrhinosinusitis |
_version_ |
1718395132040970240 |